Active Ingredient: BEPOTASTINE BESILATE
Proprietary Name: BEPOTASTINE BESILATE
Dosage Form; Route of Administration: SOLUTION/DROPS; OPHTHALMIC
Strength: 1.5%
Reference Listed Drug: No
Reference Standard: No
TE Code: AT
Application Number: A206220
Product Number: 001
Approval Date: Mar 18, 2019
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
